Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC SKI-178 | 1259484-97-3 | 99.3% | 50 MG
SDP

Supplier:  Medchemexpress LLC HY1289250MG

Encompass_Preferred

SKI-178 is a potent inhibitor of both sphingosine kinase-1 (SphK1) and sphingosine kinase-2 (SphK2). It demonstrates cytotoxicity in various cancer cell lines, including agent-sensitive and multi-agent resistant types, with IC50 concentrations ranging from 0.1 to 1.8 μM. This compound has been shown to induce apoptosis in human acute myeloid leukemia cell lines in a CDK1-dependent manner and correlates with prolonged Bcl-2 phosphorylation. In in-vivo studies, SKI-178 inhibited leukemic progression in the MLL-AF9 mouse model, leading to a decrease in white blood cell counts.

  • Potent SphK1 and SphK2 inhibitor
  • Exhibits cytotoxicity in various cancer cell lines
  • Induces apoptosis in human acute myeloid leukemia cells
  • Correlates with prolonged Bcl-2 phosphorylation
  • Inhibits leukemic progression in MLL-AF9 mouse model

Catalog No. 50-003-39143


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.